1. Home
  2. ASIX vs ANAB Comparison

ASIX vs ANAB Comparison

Compare ASIX & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASIX
  • ANAB
  • Stock Information
  • Founded
  • ASIX 2016
  • ANAB 2005
  • Country
  • ASIX United States
  • ANAB United States
  • Employees
  • ASIX N/A
  • ANAB N/A
  • Industry
  • ASIX Major Chemicals
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASIX Industrials
  • ANAB Health Care
  • Exchange
  • ASIX Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • ASIX 841.5M
  • ANAB 759.5M
  • IPO Year
  • ASIX N/A
  • ANAB 2017
  • Fundamental
  • Price
  • ASIX $28.05
  • ANAB $14.55
  • Analyst Decision
  • ASIX Strong Buy
  • ANAB Buy
  • Analyst Count
  • ASIX 2
  • ANAB 11
  • Target Price
  • ASIX $39.50
  • ANAB $42.67
  • AVG Volume (30 Days)
  • ASIX 140.6K
  • ANAB 809.3K
  • Earning Date
  • ASIX 02-14-2025
  • ANAB 11-05-2024
  • Dividend Yield
  • ASIX 2.28%
  • ANAB N/A
  • EPS Growth
  • ASIX N/A
  • ANAB N/A
  • EPS
  • ASIX 1.42
  • ANAB N/A
  • Revenue
  • ASIX $1,570,703,000.00
  • ANAB $57,172,000.00
  • Revenue This Year
  • ASIX $3.94
  • ANAB $233.68
  • Revenue Next Year
  • ASIX $7.65
  • ANAB N/A
  • P/E Ratio
  • ASIX $19.79
  • ANAB N/A
  • Revenue Growth
  • ASIX 0.98
  • ANAB 282.17
  • 52 Week Low
  • ASIX $20.86
  • ANAB $14.20
  • 52 Week High
  • ASIX $33.00
  • ANAB $41.31
  • Technical
  • Relative Strength Index (RSI)
  • ASIX 28.79
  • ANAB 30.98
  • Support Level
  • ASIX $31.08
  • ANAB $15.11
  • Resistance Level
  • ASIX $30.63
  • ANAB $16.74
  • Average True Range (ATR)
  • ASIX 0.90
  • ANAB 1.94
  • MACD
  • ASIX -0.48
  • ANAB -0.52
  • Stochastic Oscillator
  • ASIX 5.35
  • ANAB 3.00

About ASIX AdvanSix Inc.

AdvanSix Inc. is an integrated manufacturer of Nylon 6, a polymer resin and fertilizers. Nylon 6 is a synthetic material used by customers to produce engineered plastics, fibers, filaments, and films, which in turn are used in such end-products as automotive and electronic components, carpets, sports apparel, fishing nets, and food and industrial packaging. In addition, it also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process including caprolactam, ammonium sulfate fertilizers, and other chemical intermediates. Geographically, the group operates through the United States and its business is also expanding internationally but it derives the majority of its revenue from the United States region.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: